Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT01236651
Eligibility Criteria:
Inclusion Criteria: ● primigravida.
* Singleton pregnancy.
* Term gestation i.e, 38-41 weeks.
* Sure, reliable dates documented by ultrasound in the 1st half of pregnancy.
* Vertex presentation with occipito anterior position.
* Efficient uterine contractions at a rate of at least 3 to 4 contractions every 10 minutes, each contraction lasting for at least 40 seconds.
Exclusion Criteria: ● Abnormal presentation or occipito posterior position.
* Multiple pregnancies.
* Cephalo-pelvic disproportion.
* Cervical surgery in the past or history of cervical injury.
* Patients on antihypertensive therapy.
* Known hypersensitivity to drotaverine or meperidine.
* If any other spasmolytic agent had been used within 48 hours.
Healthy Volunteers:
True
Sex:
MALE
Study:
NCT01236651
Study Brief:
Protocol Section:
NCT01236651